Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2 '-C-Methyladenosine Prevents Death in a Mouse Model of West Nile Virus Infection
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60077344%3A_____%2F19%3A00511116" target="_blank" >RIV/60077344:_____/19:00511116 - isvavai.cz</a>
Alternative codes found
RIV/68081766:_____/19:00511116 RIV/61388963:_____/19:00511116 RIV/00027162:_____/19:N0000248 RIV/00216224:14310/19:00109098
Result on the web
<a href="https://aac.asm.org/content/aac/63/3/e02093-18.full.pdf" target="_blank" >https://aac.asm.org/content/aac/63/3/e02093-18.full.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1128/AAC.02093-18" target="_blank" >10.1128/AAC.02093-18</a>
Alternative languages
Result language
angličtina
Original language name
Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2 '-C-Methyladenosine Prevents Death in a Mouse Model of West Nile Virus Infection
Original language description
West Nile virus (WNV) is a medically important emerging arbovirus causing serious neuroinfections in humans and against which no approved antiviral therapy is currently available. In this study, we demonstrate that 2'-C-methyl- or 4'-azido-modified nucleosides are highly effective inhibitors of WNV replication, showing nanomolar or low micromolar anti-WNV activity and negligible cytotoxicity in cell culture. One representative of C2'-methylated nucleosides, 7-deaza-2'-C-methyladenosine, significantly protected WNV-infected mice from disease progression and mortality. Twice daily treatment at 25 mg/kg starting at the time of infection resulted in 100% survival of the mice. This compound was highly effective, even if the treatment was initiated 3 days postinfection, at the time of a peak of viremia, which resulted in a 90% survival rate. However, the antiviral effect of 7-deaza-2'-C-methyladenosine was absent or negligible when the treatment was started 8 days postinfection (i.e., at the time of extensive brain infection). The 4'-azido moiety appears to be another important determinant for highly efficient inhibition of WNV replication in vitro. However, the strong anti-WNV effect of 4'-azidocytidine and 4'-azido-aracytidine was cell type dependent and observed predominantly in porcine kidney stable (PS) cells. The effect was much less pronounced in Vero cells. Our results indicate that 2'-C-methylated or 4'-azidated nucleosides merit further investigation as potential therapeutic agents for treating WNV infections as well as infections caused by other medically important flaviviruses.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10606 - Microbiology
Result continuities
Project
<a href="/en/project/GA16-20054S" target="_blank" >GA16-20054S: Advanced studies on West Nile virus infection pathogenesis towards novel therapeutic strategies</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Antimicrobial Agents and Chemotherapy
ISSN
0066-4804
e-ISSN
—
Volume of the periodical
63
Issue of the periodical within the volume
3
Country of publishing house
US - UNITED STATES
Number of pages
14
Pages from-to
e02093-18
UT code for WoS article
000459683500026
EID of the result in the Scopus database
2-s2.0-85062297115